Heritage Pharmaceuticals Inc recalls CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION
- Recalling company
- Heritage Pharmaceuticals Inc
- Product
- CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR ORAL SOLUTION, USP, 75 mg/5 mL, Rx Only, 100 mL, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-603-51
- Reason
- Presence of Foreign Substance: presence of particles and white flakes in the reconstituted bottles.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jul 30, 2026
- Reported
- Aug 19, 2026
- Distribution
- Nationwide within the U.S
- Status
- Ongoing
- Lot / codes
- Lot #: 2411550, Exp. 2026/NOV.
- Company location
- East Brunswick, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0768-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0768-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.